DRTSW Market Analysis
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)—0.0% YoY
Profit margin0.0%
Market cap—
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -90.5%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 1.17
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Alpha Tau Medical Ltd. Warrant
Company profileAlpha Tau Medical Ltd., a clinical-stage oncology therapies company, is engaged in the research, development, and commercialization of alpha-emitting radiation therapy (Alpha DaRT) for the treatment of solid cancer in Israel and the United States. The company is headquartered in Jerusalem, Israel.
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- KIRYAT HAMADA ST. 5, JERUSALEM, ISRAEL
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Shares outstanding$0
52W high$4.28
52W low$0.20
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent